GlaxoSmithKline
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 28 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name GlaxoSmithKline as a sponsor: 28 trials, 25 as lead sponsor and 3 as collaborator.
Phase and status
| Phase | Recruiting | Active, not recruiting | Completed | Terminated | All statuses |
|---|---|---|---|---|---|
| Phase 2 | 0 | 0 | 7 | 1 | 8 |
| Phase 3 | 1 | 0 | 15 | 0 | 16 |
| Phase 4 | 0 | 1 | 3 | 0 | 4 |
| All phases | 1 | 1 | 25 | 1 | 28 |
Start year
| Start year | Trials |
|---|---|
| 2026 | 1 |
| 2023 | 2 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 6 |
| 2015 | 1 |
| 2014 | 3 |
| 2013 | 4 |
| 2012 | 1 |
| 2011 | 2 |
| 2010 | 6 |
Main conditions
Main countries
- United States
- Canada
- Spain
- United Kingdom
- Germany
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- GlaxoSmithKline
- Sponsor class
- INDUSTRY
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 28
Record details
- Record id
cardio:org-glaxosmithkline- Content hash
eb8fd249690216d2f451d92e5fb9041f4a7ab302053c48e44aa12892b7d1e4a8